0001209191-16-103494.txt : 20160229
0001209191-16-103494.hdr.sgml : 20160229
20160229174024
ACCESSION NUMBER: 0001209191-16-103494
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160225
FILED AS OF DATE: 20160229
DATE AS OF CHANGE: 20160229
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TENET HEALTHCARE CORP
CENTRAL INDEX KEY: 0000070318
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 952557091
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
BUSINESS PHONE: 469-893-2200
MAIL ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cancelmi Daniel J
CENTRAL INDEX KEY: 0001396106
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07293
FILM NUMBER: 161469944
MAIL ADDRESS:
STREET 1: 13737 NOEL ROAD
STREET 2: SUITE 100
CITY: DALLAS
STATE: TX
ZIP: 75240
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-02-25
0
0000070318
TENET HEALTHCARE CORP
THC
0001396106
Cancelmi Daniel J
1445 ROSS AVENUE
SUITE 1400
DALLAS
TX
75202
0
1
0
0
Chief Financial Officer
Common Stock
2016-02-25
4
M
0
8035
A
119986
D
Common Stock
2016-02-25
4
F
0
3427
24.81
D
116559
D
Common Stock
2016-02-25
4
M
0
13234
A
129793
D
Common Stock
2016-02-25
4
F
0
5605
24.81
D
124188
D
Common Stock
2016-02-26
4
M
0
7142
A
131330
D
Common Stock
2016-02-26
4
F
0
3025
25.68
D
128305
D
Common Stock
2016-02-26
4
M
0
14284
A
142589
D
Common Stock
2016-02-26
4
F
0
6050
25.68
D
136539
D
Common Stock
2016-02-26
4
M
0
7208
A
143747
D
Common Stock
2016-02-26
4
F
0
3053
25.68
D
140694
D
Common Stock
2016-02-26
4
M
0
7208
A
147902
D
Common Stock
2016-02-26
4
F
0
3053
25.68
D
144849
D
2015 February Restricted Stock Units
2016-02-25
4
M
0
8035
0.00
D
Common Stock
8035
16072
D
2015 February Performance-Based Restricted Stock Units
2016-02-25
4
M
0
13234
0.00
D
Common Stock
13234
26471
D
2014 February Restricted Stock Units
2016-02-26
4
M
0
7142
0.00
D
Common Stock
7142
7142
D
2014 February Performance-Based Restricted Stock Units
2016-02-26
4
M
0
14284
0.00
D
Common Stock
14284
14284
D
2013 February Restricted Stock Units
2016-02-26
4
M
0
7208
0.00
D
Common Stock
7208
0
D
2013 February Performance-Based Restricted Stock Units
2016-02-26
4
M
0
7208
0.00
D
Common Stock
7208
0
D
As previously reported, on February 25, 2015, the reporting person received a grant of 24,107 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 25, 2016, resulting in the vesting and settlement of 8,035 shares of common stock, as shown in Table I. The remaining 16,072 restricted stock units are shown in Table II, of which 8,036 are scheduled to vest on each of February 25, 2017 and February 25, 2018.
Restricted stock units convert into common stock on a one-for-one basis.
Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
As previously reported, on February 25, 2015, the reporting person received a target grant of 24,107 performance-based restricted stock units that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending December 31, 2015. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded and 164.7% of the target grant was awarded; therefore, these restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 25, 2016, resulting in the vesting and settlement of 13,234 shares of common stock, as shown in Table I. The remaining 26,471 performance restricted stock units are shown in Table II, of which 13,236 are scheduled to vest on February 25, 2017 and 13,235 are scheduled to vest on February 25, 2018.
As previously reported, on February 26, 2014, the reporting person received a grant of 21,425 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2015, resulting in the vesting and settlement of 7,141 shares of common stock. The second anniversary occurred on February 26, 2016, resulting in the vesting and settlement of 7,142 shares of common stock, as shown in Table I. The remaining 7,142 restricted stock units are shown in Table II, which are scheduled to vest on February 26, 2017.
As previously reported, on February 26, 2014, the reporting person received a target grant of 21,425 performance-based restricted stock units that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending December 31, 2014. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded and 200% of the target grant was awarded; therefore, these restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2015 resulting in the vesting and settlement of 14,282 shares of common stock. The second anniversary occurred on February 26, 2016, resulting in the vesting and settlement of 14,284 shares of common stock, as shown in Table I. The remaining 14,284 performance restricted stock units are shown in Table II, which are scheduled to vest on February 26, 2017.
As previously reported, on February 28, 2013, the reporting person received a grant of 21,623 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 28, 2014, resulting in the vesting and settlement of 7,207 shares of common stock. The second vesting date occurred on February 27, 2015 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 7,208 shares of common stock. The third vesting date occurred on February 26, 2016 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 7,208 shares of common stock, as shown in Table I.
As previously reported, on February 28, 2013, the reporting person received a target grant of 21,623 performance-based restricted stock units that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending December 31, 2013. The performance metric was met; therefore, these restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 28, 2014, resulting in the vesting and settlement of 7,207 shares of common stock. The second vesting date occurred on February 27, 2015 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 7,208 shares of common stock. The third vesting date occurred on February 26, 2016 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 7,208 shares of common stock, as shown in Table I.
Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock upon vesting.
Anthony L. Shoemaker, as Attorney-in-Fact for Daniel J. Cancelmi
2016-02-29